Azalea Health’s RCM Services Outperform Industry Standard in Recent Benchmark Study

Physician practices report strong reimbursement rates, lowering accounts receivables, strengthening cash flow ATLANTA–(BUSINESS WIRE)–#RCM—Azalea Health, a leading provider of fully-integrated cloud-based healthcare solutions and services, released today results from its internal customer survey, highlighting how providers are leveraging the company’s revenue cycle management (RCM) services throughout the year. The Azalea RCM Performance Analysis was conducted … [Read more…]

Lucence Announces Publication of Validation Study for LiquidHALLMARK ctDNA Liquid Biopsy Assay

The study, published in PLOS ONE, establishes LiquidHALLMARK’s market-leading sensitivity and identifies actionable biomarkers in majority of cancer patients and 70% of lung cancer patients; Mary Jo Mullen joins the Company as SVP, Commercial to oversee US market growth PALO ALTO, Calif.–(BUSINESS WIRE)–Lucence, the precision oncology company pioneering ultrasensitive liquid biopsy tests, is announcing the … [Read more…]

CPSI Pilots Clinical Lens to Ease Provider Data Burdens

New Technology Aims to Empower EHR Users with More Efficient Access to Clinical Information at the Point of Care MOBILE, Ala.–(BUSINESS WIRE)–$CPSI—CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced the pilot launch of Quippe Clinical Lens in partnership with Medicomp Systems. Through integration with CPSI’s Patient Data Console, a unique dashboard that presents problem-oriented … [Read more…]

Milestone Scientific Expands Access to Safe, More Comfortable and Effective Epidural for Expecting Parents During Women’s Health Month

Innovative anesthesia delivery puts women’s health first, saving patients time and reducing cost and risk of unintentional dural puncture, which can lead to severe and chronic headaches ROSELAND, N.J.–(BUSINESS WIRE)–With post epidural side effects becoming more serious than previously known, today Milestone Scientific Inc. announced the availability of its CompuFlo® Epidural instrument in hospitals and … [Read more…]

Electromed, Inc. Announces Clinical Abstract Poster at ATS Conference: Bronchiectasis Patients Showed Improved Outcomes and Reduction in Healthcare Resource Utilization When Using HFCWO Therapy

  NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (NYSE American: ELMD) today announced the results of a third-party, clinical study presented as a clinical abstract poster at the American Thoracic Society International Conference in San Francisco, CA. The study’s key findings reveal that patients who used high frequency chest wall oscillation (“HFCWO”) therapy experienced an improvement in … [Read more…]

Xponential Fitness, Inc. Announces Upcoming Conference Participation

IRVINE, Calif.–(BUSINESS WIRE)–Xponential Fitness, Inc. (NYSE: XPOF) (the “Company” or “Xponential Fitness”), the largest global franchisor of boutique fitness brands, today announced Anthony Geisler, Chief Executive Officer; John Meloun, Chief Financial Officer; and Sarah Luna, President, will participate in the following upcoming investor conferences: The Credit Suisse HALO Investment Summit to be held May 24-25, … [Read more…]

ATEC to Participate in Upcoming Investor Events

CARLSBAD, Calif.–(BUSINESS WIRE)–Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that executive management will participate in the following investor events: Todd Koning, Chief Financial Officer, will present at the Wells Fargo Securities West Coast MedTech Tour on June 2, 2022, at … [Read more…]

Virpax Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference

BERWYN, Pa.–(BUSINESS WIRE)–#pharma—Virpax® Pharmaceuticals, Inc. (“Virpax”) (NASDAQ: VRPX), a company specializing in product candidates for pain management, CNS disorders and anti-viral indications, today announced that it will be presenting virtually at the upcoming H.C. Wainwright event from Tuesday, May 24th starting at 7:00 a.m. ET through Friday, May 27th. Anthony P. Mack, Chairman & CEO of … [Read more…]

MAIA Biotechnology, Inc. Establishes Wholly Owned Subsidiaries in Romania and Australia to Support Global Development of THIO

-Expanded clinical development presence is expected to accelerate activities for THIO-101 Phase 2 Trial for NSCLC- CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs (“MAIA”), announced today that the company has established two wholly-owned subsidiaries in Romania and Australia to broaden and accelerate its global development plan … [Read more…]

Biognosys Announces Appointment of Beat Lüthi, Ph.D., as independent Board Director

The appointment will support Biognosys’ transformation to a leading provider of protein insights for the development of new breakthrough treatments ZURICH–(BUSINESS WIRE)–#ClinicalResearch–Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, announced today the appointment of Beat Lüthi, Ph.D., as Board Director. Dr. Lüthi is Chief Executive Officer of CTC Analytics … [Read more…]